A person with Alzheimer’s disease or other dementia most likely will experience significant behavioral changes, including ...

The study, which was published in the journal Alzheimer’s & Dementia Translational Research & Clinical Interventions, looked ...

The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s disease. Experts believe this will increase ...

Can a sports supplement help the brain battle Alzheimer’s? A new study finds creatine may boost a key energy pathway—and ...

Dementia in the US hits hardest among Black Americans and residents of socioeconomically disadvantaged neighborhoods, where ...

A new study, published today in Nature Communications, offers clues into how APOE isoforms differentially affect human ...

FDA approves first blood test for Alzheimer's detection. Simple blood draw replaces expensive scans and spinal taps.

Donanemab is only for use in the early stages of Alzheimer’s disease. And for now at least, it comes with a hefty price tag.

Worldwide, more than 55 million people suffer from dementia caused by Alzheimer's Disease (AD) and other conditions that destroy cells in the brain and nervous system. While there is no treatment to ...

A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for ...

A new study has found the herpes simplex virus type 1 (HSV-1), which causes cold sores, may be linked to the development of ...